29.Bilusic M, Gulley JL, Heery C, Apolo AB, Arlen P, Rauckhorst M, et al. A randomized phase II study of flutamide with or without PSA -TRICOM in nonmetastatic castration-resistant prostate cancer. J Clin Oncol 29: 2011 (suppl 7; abstr 163). 30.Scher HI, Halabi S, Tannock I, Morris M, St ernberg CN, Carducci MA, et al. Design and end points of clinical trials for pa tients with progressive prostate cancer and castrate levels of testosterone: recommenda tions of the Prostate Cancer Clinical Trials Working Group. J Clin Oncol.